Geoff Barnes

Vascular Cardiologist @umichCVC. #thrombosis, #CVcoag, #ImpSci. Co-director @MAQI_2. Board of Directors @AnticoagForum. Tweets my own. RT≠endorsement. 🏳️‍🌈

[Jay Giri @jaygirimd]

🧵 1/ First ever AHA/ACC/multi-society guidelines re: diagnosis & management of acute PE released today!

2 year effort with 38 authors from 10 specialties.

Link attached & summary in this thread:

https://t.co/uUUyUvz3pR

[Geoff Barnes @GBarnesMD]

We also tried to outline diagnostic and care pathways based on these risk categories.

[Geoff Barnes @GBarnesMD]

I'm incredibly proud to announce the release of the 2026 AHA/ACC Acute PE Guidelines. This document represents two years of hard work from a highly talented, diverse set of clinician experts. https://t.co/b72nKYXbYT and https://t.co/dGiFMNM1NL @ACCinTouch @AHAMeetings

[Geoff Barnes @GBarnesMD]

One of the most important pieces from this guideline is the new Clinical Classes for Acute PE. This new scheme encourages clinicians and researchers to more granuarly define risk profiles for patients with acute PE when determining the best acute intervention plans.

[MedscapeLIVE @MedscapeLIVE]

🚨COUNTDOWN BEGINS—Be at the #HeartofCardio Conference ❤️ in 2026 with our experts @FaRodriguezMD + @manesh_patelMD + @GBarnesMD. Secure your spot now 👉 https://t.co/PovLT5yESN

[Geoff Barnes @GBarnesMD]

Check out this great #CME session focused on Factor XI inhibitors. As exciting new science emerges over the next 2 months, this is key information that every #cardiotwitter follower will want to know!

[Med-IQ @MedIQCME]

1/21 In this #CME #MedX, @GBarnesMD provides the latest information on investigational factor XI/XIa (FXI/XIa) inhibitors and their potential role in managing stroke risk in patients with AF.

Get credit: https://t.co/CabHar3zBd

[Geoff Barnes @GBarnesMD]

🌟 I am so excited to be speaking at the 5th Annual Going Back to the Heart of Cardiology Conference January 24-26 in Miami Beach. Looking forward to sharing and learning alongside the best in the field. See you there! Register here: https://t.co/ZDKskvmE7o
#HeartofCardio

[theheartorg | Medscape @theheartorg]

15 minute AHA Recap for thromboembolic disease! ➡️ https://t.co/1qP06ZA9LE

@GBarnesMD reviews ONCO PE Trial, finding if you can tolerate an anticoagulant, then extended courses tend to not increase bleeding over the long term, but have huge benefits in preventing recurrent PE.

[Geoff Barnes @GBarnesMD]

Going live in a few minutes. Join us for this excellent conversation!!!

[Medscape @Medscape]

🩸 Do not miss this 𝐋𝐈𝐕𝐄 #𝐀𝐇𝐀𝟐𝟒 𝐫𝐞𝐜��𝐩 𝐢𝐧 𝟏 𝐇𝐎𝐔𝐑 as renowned faculty review key insights re: thromboembolic disease prevention and management. ➡️ https://t.co/mudNTle7L6

🎤 @dlbhattmd, @gbarnesmd, @DKadiandodov

[Geoff Barnes @GBarnesMD]

Does this change our standard for how long to treat cancer-associated VTE? It was a select group, but efficacy benefit without more bleeding is compelling

[Circulation @CircAHA]

#CircAHA24 PE Trial: Longer anticoagulation therapy (rivaroxaban for 18 months) had a benefit in patients with cancer and acute low-risk pulmonary embolism compared to shorter 6-month treatment. @saipon_yuji @GunmaUnivNKoita https://t.co/HnmKWPvyUu

[American College of Cardiology @ACCinTouch]

A Rare Opportunity for Emerging Leaders in CV Education - Apply Now!

Don’t miss this exclusive opportunity to apply for the prestigious Rick Nishimura, MD, MACC and Patrick T. O’Gara, MD, MACC Emerging Faculty Leadership Academy, taking place April 27 – 29, 2025. 🔗 https://t.co/jGnNoZmETs

[Saskia Middeldorp @MiddeldorpS]

Science! Have you read the #PEERLESS trial comparing
#thrombectomy (#LBMT) with #catheter-directed #thrombolysis (#CTD) for Intermediate-risk #pulmonary #embolism (#PE)? A critical read and analysis: 🧵1/5 https://t.co/BNqp9iSFy0

[Bethany Samuelson Bannow MD, MCR @bsamuelson_md]

We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not a tracked outcome, but hardly any patients were even capable of menstruation. Read our call to action for improving capture of HMB in anticoagulant trials. https://t.co/c26Y0umzOi

[Geoff Barnes @GBarnesMD]

@JoshuaBeckmanMD @AlexSullivan_MD @PVDCouncil @AHAScience Hearty congratulations!!!!

[cardio-met @cardiomet_CE]

1) Welcome to #AHA2024 #AHA24 from #Chicago! @cardiomet_ce is HERE for you with breaking news from further analysis of the #AZALEA #TIMI_71 data on #FXI inhibition for #stroke reduction in #AFib. Earn CE/#CME credit from following this 🧵!

[Shikha Jha M.D.🫀 @Shikha_Cardio]

#SUMMIT trial 🫀
Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with HFpEF & obesity.
Key slides ⬇️ @CardioNerds @AHAScience #AHA2024

[Naima Maqsood @NaimaMaqsood9]

💊 GDMT for HFrEF 👇AF incidence and overall burden

⚡️SOLVD trial and Val-HEFT trial: ACEi and ARBs👇incident AF
⚡️EMPHASIS trial: MRA 👇 incident AF
⚡️DAPA-HF: SGLT2 i 👇 incident AF
👉Effects of beta blockers on incident AF less clear

[Naima Maqsood @NaimaMaqsood9]

Say NO 🛑 to drugs! (AADs). Results of CASTLE-AF trial highlighting burden of AF between AAD vs ablation:

[ISTH @isth]

🚨 Exciting news: Our abstract submission portal for #ISTH2025 opens Nov 29! Mark your calendars, and get ready to contribute to what promises to be our most impactful Congress yet.

Abstract guidelines are now available at https://t.co/FxslPyKrwz

[Anticoagulation Forum @AnticoagForum]

🔊 Recording is now available for the "Ask the Experts" webinar. Watch here: https://t.co/JXjphYrTtl
Thank you to our amazing panelists Drs. Arthur Allen (@AAllenPharmD), Allison Burnett (@aburnett_PharmD), Geoffrey Barnes (@GBarnesMD), Tara Lech, (@AnticoagPharmD) Anita Rajasekhar (@AnitaRajUF), Bethany Samuelson Bannow for an engaging presentation!

Revisit the insightful discussions, expert insights, and valuable Q&A session on topics like:
Thrombosis and Thrombophilia Management
Valvular Disease and Anticoagulation
Women's Health
Inpatient Anticoagulation and Acute Care Management
Outpatient Care
Become an AC Forum Member to view this recording and access hundreds of other relevant resources.

Join AC Forum and create your free account today: https://t.co/hipt7w0rGa